Keirstead; Hans S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Keirstead; Hans S..The latest application filed is for "oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury".

Company Profile

3.9.11

Keirstead; Hans S. - Irvine CA
Keirstead; Hans S. - Laguna Beach CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Oligodendrocytes Derived from Human Embryonic Stem Cells for Remyelination and Treatment of Spinal Cord Injury App 20200332254 - Keirstead; Hans S. ; et al.	2020-10-22
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury Grant 10,611,998 - Keirstead , et al.	2020-04-07
IP-10 antibodies and their uses Grant 9,994,633 - Deshpande , et al. June 12, 2	2018-06-12
Stem Cell Compositions For Cosmetic And Dermatologic Use App 20180116951 - Nistor; Gabriel ; et al.	2018-05-03
Ip-10 Antibodies And Their Uses App 20150104866 - DESHPANDE; Shrikant ; et al.	2015-04-16
IP-10 antibodies and their uses Grant 8,945,546 - Deshpande , et al. February 3, 2	2015-02-03
Ip-10 Antibodies And Their Uses App 20120230998 - DESHPANDE; Shrikant ; et al.	2012-09-13
IP-10 antibodies and their uses Grant 8,258,266 - Deshpande , et al. September 4, 2	2012-09-04
Ip-10 Antibodies And Their Uses App 20100077497 - DESHPANDE; Shrikant ; et al.	2010-03-25
Oligodendrocytes Derived From Human Embryonic Stem Cells For Remyelination And Treatment Of Spinal Cord Injury App 20090232779 - Keirstead; Hans S. ; et al.	2009-09-17
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury Grant 7,579,188 - Keirstead , et al. August 25, 2	2009-08-25
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury Grant 7,285,415 - Keirstead , et al. October 23, 2	2007-10-23
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury App 20070231898 - Keirstead; Hans S. ; et al.	2007-10-04
Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration Grant 6,969,516 - Steeves , et al. November 29, 2	2005-11-29
IP-10 antibodies and their uses App 20050191293 - Deshpande, Shrikant ; et al.	2005-09-01
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury App 20050101014 - Keirstead, Hans S. ; et al.	2005-05-12
Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins App 20050008641 - Steeves, John D. ; et al.	2005-01-13
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury App 20040009593 - Keirstead, Hans S. ; et al.	2004-01-15

Company Registrations

NCAGE Code	47BQ1	KEIRSTEAD HANS S
CAGE Code	47BQ1	KEIRSTEAD, HANS S

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.